Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for Windows
490,975 results
  • Systemic bevacizumab for end-stage juvenile recurrent respiratory papillomas: A case report. [Journal Article]
    Int J Pediatr Otorhinolaryngol 2019; 128:109706Hamdi O, Dome J, … Preciado D
  • We report on two cases of severe recurrent respiratory papillomatosis (RRP) involvement where the anti-vascular endothelial growth factor (VEGF) antibody bevacizumab IV has been administered for treatment. Notably, there have not been any episodes of urgent transfer to the hospital for obstructive events since the bevacizumab was started. It is important to note however, that the disease has not …
  • Smartphones as mobile microbiological laboratories. [Review]
    Clin Microbiol Infect 2019Ong DSY, Poljak M
  • CONCLUSIONS: Recent developments in smartphone-based POC tests for infectious diseases are promising, as evidenced by results from many proof-of-concept studies. Further progress will foster large-scale implementation of smartphone-based POC as mobile microbiological laboratories in the near future.
New Search Next